Unaudited Finacial Results along with Limited Review Report for the quarter ended 30.06.2026
RESULTS
◆ Monitor Closely
HIGH RISK
📅 Filed on BSE: 04 Aug 2026, 06:05 PM IST · BSE ID: 4b6da186-dff6-4fc6-bf25-572815f914bb
View Original BSE Filing (PDF)
💡
In Simple Terms
The company reported a Rs. (10.17) Lakhs loss, plans a name change, and appointed a new Chairman and Managing Director.
🤖 AI Summary
- Unaudited net loss of Rs. (10.17) Lakhs for the quarter ended June 30, 2026, approved by Board.
- Proposed change in company name to Ananth BioOrganics Limited or similar options, subject to approvals.
- Mr. Venkata Sandeep Kumar Reddy Tikkavarapu resigned as Chairman and Non-Executive Director effective August 5, 2026.
- Mr. Sreedhara Reddy Kanaparthi redesignated as Chairman and Managing Director for three years from August 5, 2026.
- The 35th Annual General Meeting for FY 2025-26 will be held on September 23, 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Total Income (Q1 FY27)
233.66 Lakhs
Not comparable — limited prior period data.
Net Profit/(Loss) after tax (Q1 FY27)
(10.17) Lakhs
Not comparable — limited prior period data.
Basic Earnings per share (Q1 FY27)
(0.01)
Not comparable — limited prior period data.
Mr. Venkata Sandeep Kumar Reddy Tikkavarapu Shareholding
1,70,06,802
🏢 How This Affects the Company
The proposed name change indicates a potential rebranding initiative, which could influence market perception and strategic focus if approved by members and regulatory bodies.
The company reported a net loss of Rs. (10.17) Lakhs for the quarter ended June 30, 2026, indicating continued operational losses. Total income for the quarter was Rs. 233.66 Lakhs.
The change in leadership with Mr. Sreedhara Reddy Kanaparthi as Chairman and Managing Director, replacing the outgoing Chairman, impacts the top-level management structure.
The company continues to report net losses, posing a financial sustainability risk. Shareholding of the resigning Chairman and Non-Executive Director is 1,70,06,802 shares.
👥 What This Means For Shareholders
✅
Action Required
Shareholders will need to approve the change in company name and the appointment of Mr. Sreedhara Reddy Kanaparthi as Chairman and Managing Director at the upcoming Annual General Meeting.
👤
Who Is Affected
All shareholders are affected by the company's Q1 FY27 financial results showing a net loss. Shareholders will vote on the proposed name change and management appointment.
🔍
Management Signal
The management's decision to propose a name change and appoint a new Chairman and Managing Director signals an intent to reposition the company and refresh leadership.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Annual General Meeting on September 23, 2026, for resolutions on name change and directorship.
Updates on the approval of the proposed new company name from Central Registration Centre.
Next quarterly financial results for Q2 FY27 to assess performance under new leadership.
HIGH RISK
The company reported continued net losses and significant management changes, indicating ongoing operational and leadership transitions.
💡 Investor Takeaway
Gayatri BioOrganics reported a net loss of Rs. (10.17) Lakhs for the quarter ended June 30, 2026. The board approved a proposed company name change and redesignated Mr. Sreedhara Reddy Kanaparthi as Chairman and Managing Director for three years, effective August 5, 2026.
⚖️ Strengths & Concerns
⚠️ Concerns
- Reported a net loss of Rs. (10.17) Lakhs for the quarter ended June 30, 2026, continuing a trend of losses.
- Revenue from operations at Rs. 233.66 Lakhs for Q1 FY27, compared to Rs. 2 Lakhs in Q4 FY26, indicates fluctuating sales.
- Basic Earnings per share was Rs. (0.01) for Q1 FY27, reflecting the company's negative profitability.
📅 Company Track Record
Gayatri BioOrganics Ltd had previously scheduled a Board meeting for August 4, 2026, to approve Q1 FY27 unaudited financial results, and earlier for May 19, 2026, for FY26 results. The company has a history of reporting net losses, including Rs. (26.29) Lakhs in Q1 FY26 and Rs. (111.18) Lakhs for FY26.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Gayatri BioOrganics Limited's net profit/loss for Q1 FY27?
Gayatri BioOrganics Limited reported a net loss of Rs. (10.17) Lakhs for the quarter ended June 30, 2026.
What is the proposed new name for Gayatri BioOrganics Limited?
The Board approved a change in name to Ananth BioOrganics Limited or similar options, subject to various approvals.
Who is the new Chairman and Managing Director of Gayatri BioOrganics Limited?
Mr. Sreedhara Reddy Kanaparthi has been redesignated as Chairman and Managing Director, effective from August 5, 2026, for a period of three years.
When is the 35th Annual General Meeting for Gayatri BioOrganics Limited?
The 35th Annual General Meeting for FY 2025-26 is scheduled to be held on Wednesday, September 23, 2026, at 11:00 a.m.
What was the revenue from operations for Gayatri BioOrganics Limited in Q1 FY27?
Revenue from operations for Gayatri BioOrganics Limited was Rs. 233.66 Lakhs for the quarter ended June 30, 2026.
Questions based on this BSE filing only. For information purposes.